1-20 of 20
Michael DeBaun, MD, MPH
Close
Sort by
Articles

2018: The Year's Best in Sickle Cell Disease

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2018) 16 (1)
https://doi.org/10.1182/hem.V16.1.9283
Published: 2018
Articles

A New Therapy for Sickle Cell Disease: FDA Approves Oral L-glutamine for Prevention of Acute Vaso-occlusive Events in Children and Adults

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2018) 15 (6)
https://doi.org/10.1182/hem.V15.6.9016
Published: 2018
Articles

A New Strategy for the Prevention of Adverse Maternal and Fetal Outcomes in Pregnant Women With Sickle Cell Disease: The Oxygen Therapy and Pregnancy in SCD Trial (DR02G)

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2018) 15 (5)
https://doi.org/10.1182/hem.V15.5.8889
Published: 2018
Articles

Another Sickle Cell Trait Myth Bites the Dust: Sickle Cell Trait Is Not Associated With Ischemic Stroke

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2018) 15 (4)
https://doi.org/10.1182/hem.V15.4.8757
Published: 2018
Articles

Professionalism and the Written Word: Attitudes and Words Matter in Medical Care for Adults With SCD

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2018) 15 (3)
https://doi.org/10.1182/hem.V15.3.8461
Published: 2018
Articles

What We Know and Do Not Know About Chronic Pain in Adults With Sickle Cell Disease

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2018) 15 (2)
https://doi.org/10.1182/hem.V15.2.8264
Published: 2018
Articles

The Year's Best in Sickle Cell Disease for 2017

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2018) 15 (1)
https://doi.org/10.1182/hem.V15.1.8159
Published: 2018
Articles

Yet Another Complication of Sickle Cell Disease: High Incidence of Venous Thromboembolism and Its Association With Earlier Death

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2017) 14 (6)
https://doi.org/10.1182/hem.V14.6.7789
Published: 2017
Articles

Another Myth About Sickle Cell Trait Bites the Dust

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2017) 14 (5)
https://doi.org/10.1182/hem.V14.5.7573
Published: 2017
Articles

Cautiously Optimistic About Gene Therapy in Sickle Cell Disease: A New Arrow in the Quiver for Cure

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2017) 14 (4)
https://doi.org/10.1182/hem.V14.4.7463
Published: 2017
Articles

Another Therapeutic Agent in the Pipeline for Preventing Acute Vaso-Occlusive Events in Sickle Cell Disease

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2017) 14 (3)
https://doi.org/10.1182/hem.V14.3.7267
Published: 2017
Articles

A New Phase II Agent Holds Promise for First FDA Approved Therapy for Treatment of Acute Vaso-Occlusive Pain Events in SCD

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2017) 14 (2)
https://doi.org/10.1182/hem.V14.2.7115
Published: 2017
Articles

The Year's Best in Sickle Cell Disease

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2017) 14 (1)
https://doi.org/10.1182/hem.V14.1.6994
Published: 2017
Articles

Universal Precautions Help Decrease Rate of Exercise-Related Death in Patient With Sickle Cell Trait

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2016) 13 (6)
https://doi.org/10.1182/hem.V13.6.6722
Published: 2016
Articles

Confirming a Reasonable Next Step for HSCT in Children with Hemoglobinopathies

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2016) 13 (5)
https://doi.org/10.1182/hem.V13.5.5966
Published: 2016
Articles

When Is a Negative Phase III Trial Positive in Sickle Cell Anemia?

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2016) 13 (4)
https://doi.org/10.1182/hem.V13.4.5626
Published: 2016
Articles

Comparing Outcomes for Young Adults with Severe SCD Treated with HLA-Identical Sibling and Matched Unrelated HCT versus Standard Supportive Care

Sarah-Jo Stimpson, MD, Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2016) 13 (3)
https://doi.org/10.1182/hem.V13.3.5469
Published: 2016
Articles

The TWiTCH Trial

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2016) 13 (2)
https://doi.org/10.1182/hem.V13.2.4943
Published: 2016
Articles

ASH Program Successful in Promoting Minority Careers

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2011) 8 (2)
https://doi.org/10.1182/hem.V8.2.1280
Published: 2011
Articles

ASH Co-Sponsors Inaugural National Conference on Blood Disorders in Public Health and Promotes the Important Role of Hematologists

Michael DeBaun, MD, MPH
Journal: The Hematologist
The Hematologist (2010) 7 (4)
https://doi.org/10.1182/hem.V7.4.6402
Published: 2010